Bristol-Myers Squibb Q1 revenue $11.2B (-6% YoY), GAAP EPS $1.20, raises FY guidance

BRISTOL MYERS SQUIBB CO

2025-Q1 EPS reported $1.20 revenue$11,201,000,000

Total revenues $11.2B, down 6% (4% ex-FX) from $11.865B in Q1 2024.
Growth Portfolio revenues $5.6B, up 16% (18% ex-FX) driven by new launches.
GAAP EPS $1.20; non-GAAP EPS $1.80, compared to prior-year losses of $5.89 and $4.40 respectively.
FY 2025 revenue guidance raised to ~$45.8B-$46.8B, non-GAAP EPS raised to $6.70-$7.00.
CEO cites strong execution and pipeline progress; multi-year transformation plans on track.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.